Abstract B143: HRO761, a First-in-class, Clinical Stage WRN Inhibitor with Potent Preclinical Anti-Tumor Activity in MSIhigh Models
Stephane Ferretti,Isabel Jaco, Andrea Decker,Christelle Hemmerlin,Clemens Scheufler,Cornelia Quadt,Dario Sterker, Elena Gavioli,Eloisa Jimenez Nunez,Ernesta Dammassa, Fanny Schaeffer,Genevieve Albrecht,Giorgia Clementi,Hansjoerg Martus,Jacques Hamon, Juergen Hinrichs,Laurent Laborde, Marion Dourdoigne, Michele Moschetta, Ramona Stump,Rita Andraos-Rey, Sarah Welly,Stephanie Barbe,Vincent Romanet,Markus Reschke,Ruben De Kanter,Michael Jensen,Henrik Moebitz,Marta Cortes Cros Molecular Cancer Therapeutics（2023）
AI 理解论文
溯源树
样例
